Vitamin K Administration Guidelines
Vitamin K should be administered to all newborns at birth, with intramuscular injection being the preferred route (1 mg vitamin K1), though oral regimens are acceptable alternatives in specific situations. 1, 2
Newborns and Infants
Healthy Term Newborns
- Intramuscular (IM) route (preferred): 1 mg vitamin K1 as a single dose at birth 1, 2
- Oral route alternatives (if IM not possible or refused):
- Option 1: 3 × 2 mg vitamin K1 orally at birth, at 4-6 days, and at 4-6 weeks
- Option 2: 2 mg vitamin K1 orally at birth, followed by weekly doses of 1 mg for 3 months 2
High-Risk Newborns
For infants with increased bleeding risk (premature, perinatal asphyxia, difficult delivery, delayed feeding, liver disease):
- First dose must be administered via IM or slow IV route 3, 4
- Subsequent doses should be individualized based on clinical status 4
Preterm and Term Infants on Parenteral Nutrition
Special Situations
Exclusively Breastfed Infants
- Higher risk of vitamin K deficiency due to low concentrations in breast milk 3, 4
- After initial prophylaxis, weekly oral administration of 2 mg (or 25 μg/day) vitamin K until completion of breastfeeding 4
Infants of Mothers on Medications Affecting Vitamin K
For mothers taking anticoagulants, anticonvulsants, or barbiturates:
- Antenatal maternal prophylaxis: 10-20 mg/day orally for 15-30 days before delivery to prevent early VKDB 4
- Newborns require special supplementation protocol according to local policy 1
Vitamin K for Warfarin Reversal
Non-Urgent Reversal (INR 5-9, No Significant Bleeding)
- Omit next 1-2 doses of warfarin and give vitamin K1 1-2.5 mg orally 1
- INR should fall within 24 hours 1
Urgent Reversal (INR >9, No Significant Bleeding)
Emergency Reversal (Serious Bleeding or Major Overdose)
- Vitamin K1 10 mg by slow IV infusion (over 30 minutes) 1, 5
- Supplement with fresh plasma or prothrombin complex concentrate 1, 5
- Additional doses of vitamin K1 may be needed every 12 hours 1
Monitoring
- Classical coagulation tests can be used in low-risk infants for indirect evaluation of vitamin K status 1
- Undercarboxylated Serum Vitamin K-Dependent Proteins (PIVKA-II) are useful biomarkers for subclinical deficiency in at-risk groups 1, 3
Important Considerations
- Document date, dose, and mode of administration for all vitamin K prophylaxis 2
- Record parental refusal after adequate information is provided due to risk of late VKDB 2
- If an infant vomits within 1 hour of oral administration, repeat the dose 2
- The oral route is not appropriate for preterm infants, those with cholestasis, impaired intestinal absorption, or those too unwell to take oral vitamin K1 2
Cautions
- A single dose of 0.2 mg IM vitamin K has been reported as insufficient to prevent late VKDB in exclusively breastfed infants 6
- Vitamin K1 administered IV can rarely cause anaphylactoid reactions with bronchospasm and cardiac arrest 1
- Rapid reversal of warfarin with vitamin K may return patients to a prothrombotic state 5
The evidence strongly supports universal vitamin K prophylaxis for all newborns, with the intramuscular route being most reliable for preventing the potentially fatal vitamin K deficiency bleeding.